| Schedule of Segment Information |
The following table is a summary of segment information for three months ended March 31, 2024 and 2023 (amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
|
March 31, 2024 |
|
March 31, 2023 |
|
|
|
| Net revenues |
|
|
|
|
|
|
| Diagnostic services |
$ |
— |
|
|
$ |
14,524 |
|
|
|
|
| Consumer products |
3,634 |
|
|
4,779 |
|
|
|
|
| Consolidated net revenue |
3,634 |
|
|
19,303 |
|
|
|
|
| Cost of revenue |
|
|
|
|
|
|
| Diagnostic services |
720 |
|
|
5,222 |
|
|
|
|
| Consumer products |
3,347 |
|
|
3,561 |
|
|
|
|
| Consolidated cost of revenue |
4,067 |
|
|
8,783 |
|
|
|
|
| Depreciation and amortization expense |
|
|
|
|
|
|
| Diagnostic services |
801 |
|
|
931 |
|
|
|
|
| Consumer products |
804 |
|
|
306 |
|
|
|
|
| Total Depreciation and amortization expense |
1,605 |
|
|
1,237 |
|
|
|
|
| Operating and other expenses |
6,793 |
|
|
8,719 |
|
|
|
|
| Income (loss) from operations, before income taxes |
|
|
|
|
|
|
| Diagnostic services |
(3,345) |
|
|
4,397 |
|
|
|
|
| Consumer products |
(1,655) |
|
|
(1,029) |
|
|
|
|
| Unallocated corporate |
(3,831) |
|
|
(2,804) |
|
|
|
|
| Total (loss) income from operations, before income taxes |
(8,831) |
|
|
564 |
|
|
|
|
| Income tax benefit (expense) |
2,566 |
|
|
(14) |
|
|
|
|
| Total (loss) income from operations, after income taxes |
(6,265) |
|
|
550 |
|
|
|
|
| Net (loss) income |
$ |
(6,265) |
|
|
$ |
550 |
|
|
|
|
The following table is a summary of segment information as of March 31, 2024 and December 31, 2023 (amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
December 31, 2023 |
| ASSETS |
|
|
|
| Diagnostic services |
$ |
42,296 |
|
|
$ |
44,221 |
|
| Consumer products |
23,773 |
|
|
38,358 |
|
| Unallocated corporate |
23,963 |
|
|
9,348 |
|
| Total assets |
$ |
90,032 |
|
|
$ |
91,927 |
|
|